Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Fellows are established scholars with proven research excellence in data science, artificial intelligence (AI), or a related field.

In the centre we see a photo of a man. In the background there is a network-like illustration.

Dr Hashem Koohy, Associate Professor of Systems Immunology and head of the Machine Learning and Integrative Approaches in Immunology Group based in both the Centre for Computational Biology and the MRC Human Immunology Unit, is one of 33 researchers from the University of Oxford to be named as an Alan Turing Institute Fellow for the 2021-22 academic year.

The Alan Turing Institute is the UK’s national institute for data science and AI, with research spanning the theoretical foundations of data science, ethical issues, as well as cutting-edge applications of data and AI.

Read the full story on the Oxford University website.

Similar stories

Many Long COVID patients continue to experience symptoms one year after hospital discharge

People who were hospitalised with COVID-19 and continued to experience symptoms five months later, show limited further recovery one year after hospital discharge according to the latest results of a major national study.

Spin-out company Alethiomics launches

The enterprise will focus on developing targeted therapies for a specific family of blood cancers.

Interview with Excellence Award winner Dr Susan Shapiro

A member of the Oxford Centre For Haematology, Dr Shapiro, was recently interviewed by the Royal College of Pathologists.

Iron integral to the development of life on Earth – and the possibility of life on other planets

A collaboration between researchers at the MRC WIMM and Department of Earth Sciences uncovers the importance of iron for the development of complex life on Earth.

Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease

Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.